<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05054868</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00001123</org_study_id>
    <nct_id>NCT05054868</nct_id>
  </id_info>
  <brief_title>Ketorolac vs Oxycodone for Great Toe Arthrodesis</brief_title>
  <official_title>Effect of Ketorolac Administration on Post-operative Narcotic Utilization and Union Rates in Great Toe Arthrodesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medstar Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medstar Health Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study reviews if taking ketorolac, after a joint fusion procedure, can decrease the need&#xD;
      for taking oxycodone (standard of care) for pain relief. The study also investigates if&#xD;
      ketorolac affects bone healing after surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study reviews if taking ketorolac, after a joint fusion procedure, can decrease the need&#xD;
      for taking oxycodone (standard of care) for pain relief. The study also investigates if&#xD;
      ketorolac affects bone healing after surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 14, 2020</start_date>
  <completion_date type="Anticipated">July 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2024</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain scores - collected at baseline (standard of care) and for the study using a study survey on days 3, 7, and 14 after surgery.</measure>
    <time_frame>From baseline to 14 days after the surgery</time_frame>
    <description>To study if postop ketorolac provides effective pain relief and helps reduce the need to take oxycodone. Participants will complete a short survey on Days 3, 7, and 14 after surgery. Participants will be asked to provide VAS pain scores, on a scale of 1-10, for the past 24 hours on Days 3, 7, and 14 after surgery.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quantitative pain management - measured using a study survey.</measure>
    <time_frame>14 days after the surgery</time_frame>
    <description>To study if postop ketorolac provides effective pain relief and helps reduce the need to take oxycodone. Participants will complete a short survey on Days 3, 7, and 14 after surgery. The survey will ask the following set of questions-&#xD;
number of pills (oxycodone and/or ketorolac) consumed&#xD;
if the pain medicine(s) needed to be refilled&#xD;
discontinuation date &amp; reason&#xD;
side effects, if any&#xD;
the effectiveness of the pain medicine(s)&#xD;
preference for ketorolac or oxycodone, if applicable</description>
  </primary_outcome>
  <other_outcome>
    <measure>Bone fusion - doctor will review the 3 month postop x-ray to see if the bones have fused at the site of surgery</measure>
    <time_frame>Approximately 90 days after surgery (or until 3-month post-op visit is completed)</time_frame>
    <description>To study if postop ketorolac affects bone fusion. This will be assessed by comparing the routine x-rays collected at the baseline visit to the routine x-rays taken at the 3-month postop visit.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Arthrodesis</condition>
  <arm_group>
    <arm_group_label>Group 1 (Control group) - Oxycodone only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects randomized to this group will receive oxycodone for postop pain management (standard of care).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2 (Treatment group) - Oxycodone and Ketorolac</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects randomized to this group will receive oxycodone and ketorolac for postop pain management.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxycodone</intervention_name>
    <description>Subjects randomized to the control group will receive oxycodone for postop pain management (standard of care).</description>
    <arm_group_label>Group 1 (Control group) - Oxycodone only</arm_group_label>
    <arm_group_label>Group 2 (Treatment group) - Oxycodone and Ketorolac</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketorolac</intervention_name>
    <description>Subjects randomized to the treatment group will receive oxycodone and ketorolac for postop pain management.</description>
    <arm_group_label>Group 2 (Treatment group) - Oxycodone and Ketorolac</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18 - 75 years.&#xD;
&#xD;
          -  Women of childbearing potential must have a negative serum or urine pregnancy test&#xD;
             results within 24 hours before the first dose of ketorolac.&#xD;
&#xD;
          -  Primary elective great toe MTP arthrodesis (CPT 28750). Other forefoot procedures&#xD;
             often performed in conjunction with toe fusion will be included (CPT codes 28308,&#xD;
             28285, 28270).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Chronic pain syndrome, CRPS or fibromyalgia&#xD;
&#xD;
          -  Revision procedures&#xD;
&#xD;
          -  Use of allograft bone at the fusion site&#xD;
&#xD;
          -  Tobacco use&#xD;
&#xD;
          -  Diabetes&#xD;
&#xD;
          -  Narcotic abuse or IV drug abuse&#xD;
&#xD;
          -  Any CPT codes involving the midfoot, hindfoot, and/or ankle&#xD;
&#xD;
          -  Unable to take NSAIDs secondary to medical comorbidities such as kidney disease&#xD;
             (impaired renal function with CrCl â‰¤ 50 ml/min) or gastric ulcers&#xD;
&#xD;
          -  Weight &lt; 50 kg&#xD;
&#xD;
          -  Does not speak or read English&#xD;
&#xD;
          -  If pregnant or planning to become pregnant or breastfeeding&#xD;
&#xD;
          -  Non-independent dweller (prisoner)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Garima V. Arora</last_name>
    <phone>410-554-2893</phone>
    <email>garima.v.arora@medstar.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>MedStar Union Memorial Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21218</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Garima V. Arora</last_name>
      <phone>410-554-2893</phone>
      <email>garima.v.arora@medstar.net</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 23, 2021</study_first_submitted>
  <study_first_submitted_qc>September 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 23, 2021</study_first_posted>
  <last_update_submitted>September 23, 2021</last_update_submitted>
  <last_update_submitted_qc>September 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>big toe arthrodesis</keyword>
  <keyword>big toe</keyword>
  <keyword>joint fusion</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketorolac</mesh_term>
    <mesh_term>Oxycodone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

